Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Retapamulin
ID: ALA5282170
Chembl Id: CHEMBL5282170
Max Phase: Preclinical
Molecular Formula: C30H47NO4S
Molecular Weight: 517.78
Associated Items:
ID: ALA5282170
Chembl Id: CHEMBL5282170
Max Phase: Preclinical
Molecular Formula: C30H47NO4S
Molecular Weight: 517.78
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CS[C@@H]2CCC3CCC2N3C)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C30H47NO4S/c1-7-28(4)16-24(35-25(33)17-36-23-11-9-20-8-10-21(23)31(20)6)29(5)18(2)12-14-30(19(3)27(28)34)15-13-22(32)26(29)30/h7,18-21,23-24,26-27,34H,1,8-17H2,2-6H3/t18-,19+,20?,21?,23-,24-,26?,27+,28-,29+,30+/m1/s1
Standard InChI Key: XPDWSVPFMYOLIJ-MOLMKHOXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 517.78 | Molecular Weight (Monoisotopic): 517.3226 | AlogP: 5.25 | #Rotatable Bonds: 5 |
Polar Surface Area: 66.84 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: ┄ | CX Basic pKa: 9.33 | CX LogP: 4.75 | CX LogD: 2.83 |
Aromatic Rings: ┄ | Heavy Atoms: 36 | QED Weighted: 0.40 | Np Likeness Score: 1.71 |
1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y.. (2023) Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives., 14 (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004] |
Source(1):